Ashleigh Scott

13PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPsycholinguistics (incl. speech production and comprehension)Epigenetics (incl. genome methylation and epigenomics)Forensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 11, 2026
Authors' reply to 'Comments on dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy'.

|Apr 23, 2026
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS.

|Mar 13, 2026
Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy.

Ashleigh P Scott, Ada Lo, Ying Xia

|Jan 27, 2025
A novel TERT variant associated with a telomere biology disorder and challenges in variant classification.

Vahid Pazhakh, Lucy C Fox, Nicole Den Elzen

|Oct 27, 2023
Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia.

Philip Wong, David C Whiteman, Catherine M Olsen

|Aug 03, 2023
PET assessment of acute gastrointestinal graft versus host disease.

Ashleigh P Scott, Andrea Henden, Glen A Kennedy

Pageof 3

Frequent Collaborators

4 joint publications

Siok-Keen Tey

3 joint publications

Andrea Henden

2 joint publications

Philip Wong

2 joint publications

Jason P Butler